Evidence map›Paper›PMID 19075048›Full record

ArticleAntimicrobial agents and chemotherapy2009

In vitro susceptibility of Borrelia spielmanii to antimicrobial agents commonly used for treatment of Lyme disease.

Kristina Morgenstern, Georg Baljer, Douglas E Norris, Peter Kraiczy, Christa Hanssen-Hübner, Klaus-Peter Hunfeld

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. The In Vitro Antimicrobial Susceptibility ofPathogens (Basel, Switzerland) · 2023
    Review
  4. Antimicrobial agents and chemotherapy · 2017
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Kristina MorgensternInstitute of Medical Microbiology and Infection Control, University Hospital of Frankfurt, Frankfurt, Main, Germany. Kristina.Morgenstern@vetmed.uni-giessen.de
Georg Baljer
Douglas E Norris
Peter Kraiczy
Christa Hanssen-Hübner
Klaus-Peter Hunfeld
Goethe University Frankfurt · DEJohns Hopkins University · USUniversity Hospital Frankfurt · DEUniversity of Giessen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ten isolates of the recently delineated genospecies Borrelia spielmanii were tested against antimicrobial agents used to treat Lyme disease and compared to eight isolates of the other three human-pathogenic borrelial genospecies. Despite some small but significant differences in four out of eight antibiotic agents, the susceptibility pattern of B. spielmanii mainly parallels that of the other known human-pathogenic members of the B. burgdorferi sensu lato complex.

Indexed as

Anti-Infective AgentsBorrelia burgdorferiBorrelia burgdorferi GroupGuidelines as TopicHumansLyme DiseaseMicrobial Sensitivity TestsTime FactorsAnti-Infective Agents

Identifiers

PMID19075048
PMCPMC2650570
OpenAlexW2096346695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.